284 related articles for article (PubMed ID: 34016597)
1. Function, Failure, and the Future Potential of Tregs in Type 1 Diabetes.
Bettini M; Bettini ML
Diabetes; 2021 Jun; 70(6):1211-1219. PubMed ID: 34016597
[TBL] [Abstract][Full Text] [Related]
2. Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes.
Volfson-Sedletsky V; Jones A; Hernandez-Escalante J; Dooms H
Front Immunol; 2021; 12():635767. PubMed ID: 33815387
[TBL] [Abstract][Full Text] [Related]
3. Antigen-Specific Treg Therapy in Type 1 Diabetes - Challenges and Opportunities.
Serr I; Drost F; Schubert B; Daniel C
Front Immunol; 2021; 12():712870. PubMed ID: 34367177
[TBL] [Abstract][Full Text] [Related]
4. Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes.
Haque M; Lei F; Xiong X; Das JK; Ren X; Fang D; Salek-Ardakani S; Yang JM; Song J
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30777937
[TBL] [Abstract][Full Text] [Related]
5. Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?
Visperas A; Vignali DA
J Immunol; 2016 Nov; 197(10):3762-3770. PubMed ID: 27815439
[TBL] [Abstract][Full Text] [Related]
6. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS
PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784
[TBL] [Abstract][Full Text] [Related]
7. Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective.
Yu H; Paiva R; Flavell RA
Immunology; 2018 Feb; 153(2):161-170. PubMed ID: 29155454
[TBL] [Abstract][Full Text] [Related]
8. High self-reactivity drives T-bet and potentiates Treg function in tissue-specific autoimmunity.
Sprouse ML; Scavuzzo MA; Blum S; Shevchenko I; Lee T; Makedonas G; Borowiak M; Bettini ML; Bettini M
JCI Insight; 2018 Jan; 3(2):. PubMed ID: 29367462
[TBL] [Abstract][Full Text] [Related]
9. Targeting CD44 augments the efficacy of Tregs in autoimmune diabetes.
Li CR; Mueller EE; Bradley LM
Immunol Lett; 2015 Feb; 163(2):199-205. PubMed ID: 25447401
[TBL] [Abstract][Full Text] [Related]
10. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
Jaeckel E; Mpofu N; Saal N; Manns MP
Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
[TBL] [Abstract][Full Text] [Related]
11. The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes.
Dong S; Hiam-Galvez KJ; Mowery CT; Herold KC; Gitelman SE; Esensten JH; Liu W; Lares AP; Leinbach AS; Lee M; Nguyen V; Tamaki SJ; Tamaki W; Tamaki CM; Mehdizadeh M; Putnam AL; Spitzer MH; Ye CJ; Tang Q; Bluestone JA
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34324441
[TBL] [Abstract][Full Text] [Related]
12. Treg gene signatures predict and measure type 1 diabetes trajectory.
Pesenacker AM; Chen V; Gillies J; Speake C; Marwaha AK; Sun A; Chow S; Tan R; Elliott T; Dutz JP; Tebbutt SJ; Levings MK
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730852
[TBL] [Abstract][Full Text] [Related]
13. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization.
Li CR; Deiro MF; Godebu E; Bradley LM
J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune Diabetes: An Overview of Experimental Models and Novel Therapeutics.
You S; Chatenoud L
Methods Mol Biol; 2016; 1371():117-42. PubMed ID: 26530798
[TBL] [Abstract][Full Text] [Related]
15. Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21.
Clough LE; Wang CJ; Schmidt EM; Booth G; Hou TZ; Ryan GA; Walker LS
J Immunol; 2008 Apr; 180(8):5393-401. PubMed ID: 18390721
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression.
Sebastiani G; Ventriglia G; Stabilini A; Socci C; Morsiani C; Laurenzi A; Nigi L; Formichi C; Mfarrej B; Petrelli A; Fousteri G; Brusko TM; Dotta F; Battaglia M
Sci Rep; 2017 Jul; 7(1):6897. PubMed ID: 28761107
[TBL] [Abstract][Full Text] [Related]
17. FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children.
Viisanen T; Gazali AM; Ihantola EL; Ekman I; Näntö-Salonen K; Veijola R; Toppari J; Knip M; Ilonen J; Kinnunen T
Front Immunol; 2019; 10():19. PubMed ID: 30723474
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
Front Immunol; 2019; 10():1733. PubMed ID: 31417546
[TBL] [Abstract][Full Text] [Related]
19. Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.
Haque M; Das JK; Xiong X; Song J
Curr Diab Rep; 2019 Aug; 19(10):89. PubMed ID: 31471667
[TBL] [Abstract][Full Text] [Related]
20. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
